Guidelines for Control of Meningococcal Disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease

Overview

Journal CMAJ

Date 1994 Jun 1

PMID 8199959

Citations 3

Affiliations

Soon will be listed here.

Citing Articles

Estimating costs associated with a community outbreak of meningococcal disease in a colombian Caribbean city.

Pinzon-Redondo H, Coronell-Rodriguez W, Diaz-Martinez I, Guzman-Corena A, Constenla D, Alvis-Guzman N J Health Popul Nutr. 2014; 32(3):539-48.

PMID: 25395916 PMC: 4221459.

Risk and prevention of meningococcal disease among education workers: A review.

De Wals P, Deshaies P, De Serres G, Duval B, Goulet L, Pouliot B Can J Infect Dis. 2007; 15(2):89-93.

PMID: 18159482 PMC: 2094960. DOI: 10.1155/2004/370415.

Cost-benefit model comparing two alternative immunisation programmes against serogroup C meningococcal disease: for Quebec residents aged 2 months to 20 years.

Rancourt C, Gregoire J, Simons W, Dostie A Pharmacoeconomics. 2003; 21(6):429-42.

PMID: 12678569 DOI: 10.2165/00019053-200321060-00006.

References

Goldschneider I, LEPOW M, Gotschlich E, Mauck F, Bachl F, Randolph M . Immunogenicity of group A and group C meningococcal polysaccharides in human infants. J Infect Dis. 1973; 128(6):769-76. DOI: 10.1093/infdis/128.6.769. View

Schwartz B . Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections. Rev Infect Dis. 1991; 13 Suppl 2:S170-3. DOI: 10.1093/clinids/13.supplement_2.s170. View

Gold R, LEPOW M, Goldschneider I, Draper T, Gotschlich E . Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J Clin Invest. 1975; 56(6):1536-47. PMC: 333132. DOI: 10.1172/JCI108235. View

Jacobson J, Camargos P, Ferreira J, McCormick J . The risk of meningitis among classroom contacts during an epidemic of meningococcal disease. Am J Epidemiol. 1976; 104(5):552-5. DOI: 10.1093/oxfordjournals.aje.a112329. View

Makela P, Peltola H, Kayhty H, Jousimies H, PETTAY O, Ruoslahti E . Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis. 1977; 136 Suppl:S43-50. DOI: 10.1093/infdis/136.supplement.s43. View

Peltola H, Makela H, Kayhty H, Jousimies H, Herva E, HALLSTROM K . Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med. 1977; 297(13):686-91. DOI: 10.1056/NEJM197709292971302. View

Edwards E, Devine L, Sengbusch G, Ward H . Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand J Infect Dis. 1977; 9(2):105-10. DOI: 10.3109/inf.1977.9.issue-2.09. View

Feigin R, Baker C, Herwaldt L, Lampe R, Mason E, Whitney S . Epidemic meningococcal disease in an elementary-school classroom. N Engl J Med. 1982; 307(20):1255-7. DOI: 10.1056/NEJM198211113072007. View

De Wals P, Hertoghe L, DE MAEYER-CLEEMPOEL S, REGINSTER-HANEUSE G, Dachy A, Bouckaert A . Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts. J Infect. 1981; 3(1 Suppl):53-61. DOI: 10.1016/s0163-4453(81)80009-6. View

10.

Judson F, Ehret J . Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis. Lancet. 1984; 2(8417-8418):1462-3. DOI: 10.1016/s0140-6736(84)91647-7. View

11.

Hudson P, Vogt R, Heun E, Brondum J, Coffin R, Plikaytis B . Evidence for school transmission of Neisseria meningitidis during a Vermont outbreak. Pediatr Infect Dis. 1986; 5(2):213-7. DOI: 10.1097/00006454-198603000-00011. View

12.

Pugsley M, Dworzack D, HOROWITZ E, Cuevas T, Sanders Jr W, Sanders C . Efficacy of ciprofloxacin in the treatment of nasopharyngeal carriers of Neisseria meningitidis. J Infect Dis. 1987; 156(1):211-3. DOI: 10.1093/infdis/156.1.211. View

13.

RENKONEN O, Sivonen A, Visakorpi R . Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland. Antimicrob Agents Chemother. 1987; 31(6):962-3. PMC: 284224. DOI: 10.1128/AAC.31.6.962. View

14.

Pugsley M, Dworzack D, Roccaforte J, Sanders C, Bakken J, Sanders Jr W . An open study of the efficacy of a single dose of ciprofloxacin in eliminating the chronic nasopharyngeal carriage of Neisseria meningitidis. J Infect Dis. 1988; 157(4):852-3. DOI: 10.1093/infdis/157.4.852. View

15.

Schwartz B, Fontaine R, Aashi J, Hightower A, Broome C, Music S . Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet. 1988; 1(8597):1239-42. DOI: 10.1016/s0140-6736(88)92069-7. View

16.

Gaunt P, Lambert B . Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Chemother. 1988; 21(4):489-96. DOI: 10.1093/jac/21.4.489. View

17.

Dworzack D, Sanders C, HOROWITZ E, Allais J, Sookpranee M, Sanders Jr W . Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrob Agents Chemother. 1988; 32(11):1740-1. PMC: 175963. DOI: 10.1128/AAC.32.11.1740. View

18.

Kaiser A, Hennekens C, SASLAW M, Hayes P, Bennett J . Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population. J Infect Dis. 1974; 130(3):217-24. DOI: 10.1093/infdis/130.3.217. View